Molecular Medicine

molecular medicineThe Molecular Medicine Residency Pathway within the Categorical Medicine Residency is designed for individuals who are interested in pursuing a career that emphasizes bench research in combination with the practice of medicine. The overarching goal of the program is to train the next generation of transformative laboratory-based physician-scientists.

The Molecular Medicine Residency Pathway provides specialized, individualized attention to each participant’s development as a bench scientist while maintaining the same broad and intensive exposure to clinical medicine that is enjoyed by all UCSF categorical internal medicine residents. Admission to the program is accompanied by a guaranteed subspecialty fellowship position within the Department of Medicine, contingent upon satisfactory completion of residency training. Successful applicants demonstrate potential for excellence in both clinical care and laboratory research, and will have completed a successful MD/PhD program or an in-depth research experience of at least one year.

Curriculum

Molecular Medicine Residents receive personal mentoring in selecting their area of research and choosing potential laboratories that may be of interest to them for postdoctoral training during their subspecialty fellowship. They also meet regularly as a group during the R2 (and R3 year, if applicable) for career development seminars, journal club presentations, and faculty research program presentations. Molecular Medicine Residents present cases that highlight pathophysiology to other UCSF residents in addition to UCSF MSTP students, and have an opportunity to participate in longitudinal mentorship with students and fellows. There are occasional social events with the broader Molecular Medicine community. Dedicated time for scholarly activity is provided during the R2 year (and R3 year, if applicable). During the R2 year, Molecular Medicine Residents attend an annual off-site 3-day research retreat of the Biomedical Sciences Program, where they can learn more about the rich scientific opportunities at UCSF and an have opportunity to fully immerse themselves in basic/translational science. Historically, the majority of Molecular Medicine Residents have opted to short-track into the ABIM Research Pathway, pending approval from the Categorical Residency Program Director.

Current Molecular Medicine Residents

*Learn more about current and former Molecular Medicine residents at UCSF.

Year

Name and Degree(s)

Degree Granting Institution

2022 Jawara Allen, MD, PhD
 
Johns Hopkins University
2022 Miranda Culley, MD, PhD 
 
University of Pittsburgh
2022 Bohao Liu, MD, PhD 
 
Columbia University
2022 Daniel Lyons, MD, PhD
 
University of Michigan
2022 Trisha Macrae, MD, PhD 
 
University of California, San Francisco
2022 Suhas Rao, MD, PhD
 
Stanford University

2021

Nia Adeniji, MD

Stanford University

2021

Erik Bao, MD

Harvard University

2021

Sherry Chao, MD, PhD

University of North Carolina, Chapel Hill

2021

Adolfo Cuesta, MD, PhD

University of California, San Francisco

2021

John Lazar, MD, PhD

University of Washington

2021

Ramya Parameswaran, MD, PhD

University of Chicago

2021

Gloria Tavera, MD, PhD

Case Western Reserve University

2021

Julia Wagner, MD, PhD 

Washington University in St. Louis

2021

Allison Wong, MD PhD

University of California, San Francisco

2021  Constance Wu, MD 
 
Harvard University

2020

Benjamin Hoffman, MD, PhD

Columbia University

2020

Alissa Kleinhenz, MD

University of Michigan

2020

Coyin Oh, MD 

Harvard University

Recent Participants

Degree Granting Institution Name Subspecialty
2020 University of Washington Erin dela Cruz, MD, PhD Infectious Diseases, UCSF
2020 Washington University, St. Louis
 
Vivek Durai, MD, PhD Cardiology, UCSF
2020 University of Utah
 
Nathan Krah, MD, PhD Hematology/Oncology, University of Utah
2020 Harvard University Donna Leet, MD Gastroenterology, UCSF
2020 UCSF
 
Sophia Levan, MD, PhD Pulmonary and Critical Care, UCSF
2020 Cornell University
 
Alejandro Lopez, MD, PhD Gastroenterology, UCSF
2020 University of Chicago Rangarajan Nadadur, MD, PhD Cardiology, UCSF
2020 Cornell University
 
Kimberly Rickman, MD PhD Hematology and Oncology, UCSF
2019 UCSF
 
Ryan Chang, MD, PhD Hematology and Oncology, UCSF
2019 Harvard University
 
Mai Dao, MD Gastroenterology, UCSF

2019 Faculte de Medecine Paris Descartes

Charlotte Hurabielle-Claverie, MD, PhD

Rheumatology, UCSF

2019 Boston University

Anjali Jacob, MD, PhD

Pulmonary and Critical Care, UCSF

2019 University of Chicago

Matthew Jones, MD, PhD

Hematology and Oncology, UCSF

2019 Harvard University

Vipul Kumar, MD, PhD

Hematology and Oncology, UCSF

2019 UCSF
 
Andrew Lechner, MD, PhD Pulmonary and Critical Care, UCSF
2019 Harvard University
 
Quinlan Sievers, MD, PhD Hematology and Oncology, UCSF

2019 Harvard University

Jeremiah Wala, MD, PhD

Hematology and Oncology, DFCI

2019 UCSF
 
Robert Weber, MD, PhD Endocrinology, UCSF

2018 UCSF

Christina Homer, MD, PhD

Infectious Diseases, UCSF

2018 University of Pennsylvania

Sarah Hsu, MD, PhD

Hematology and Oncology, UCSF

2018 Duke University

Jerry Lee, MD

Hematology and Oncology, UCSF

2018 UCSF

T. Richard Parenteau, MD, PhD

Geriatrics, UCSF

2018 University of Iowa

Joshua Schoenfeld, MD, PhD

Hematology and Oncology, Memorial Sloan-Kettering Cancer Center

2018 Harvard University

Travis Zack, MD, PhD

Hematology and Oncology, UCSF

2018 UCSF

John Huizar, MD

Rheumatology, UCSF

2018 Johns Hopkins University

Worawan Limpitikul, MD, PhD

Cardiology, MGH 

2018 Columbia University

Natasha Spottiswoode, MD, PhD

Infectious Diseases, UCSF

2017 New York University

Adam Blaisdell, MD, PhD

Gastroenterology, UCSF

2017 Univeristy of Pittsburgh

John Demko, MD

Nephrology, UCSF

2017 University of California, Irvine

Kelly Fitzgerald, MD

Hematology and Oncology, Memorial Sloan-Kettering Cancer Center

2017 Yale

Brendan Huang, MD, PhD

Pulmonary Disease and Critical Care Medicine, UCLA

2017 University of North Carolina

Meghan Jobson, MD, PhD

Palliative Care, UCSF

2017 Cornell

Corynn Kasap, MD, PhD

Hematology and Oncology, UCSF

2017 Cornell

Maxime Kinet, MD, PhD

Rheumatology, UCSF

2017 Icahn School of Medicine at Mt Sinai

Noa Simchoni, MD, PhD

Hospital Medicine, UCSF

2017 UCSF

Noah Younger, MD, PhD

Hematology and Oncology, UCSF

2016 Yale

Nancy Allen, MD, PhD

Pulmonary Disease and Critical Care Medicine, UCSF

2016 Columbia

Stewart Cao, MD, PhD

Gastroenterology, Washington University, St. Louis

2016 University of Michigan

Cailin Collins, MD, PhD

Hematology and Oncology, Stanford University

2016 Baylor

Andrew Folick, MD, PhD

Endocrinology, UCSF

2016 Icahn School of Medicine at Mount Sinai

Arielle Klepper, MD, PhD

Gastroenterology, UCSF

2016 Pennsylvania State University College of Medicine

Michelle Matzko, MD, PhD

Infectious Diseases, MGH/BWH

2016 UCSF

Alex Mohapatra, MD, PhD

Pulmonary Disease and Critical Care Medicine, UCSF

2016 Baylor

Kapil Saxena, MD

Hematology and Oncology, MDACC

2015 University of Pennsylvania

Chukwuka Didigu, MD, PhD

Hematology and Oncology, UCSF

2015 Harvard

Laura Huppert, MD,

Hematology and Oncology, UCSF

2015 Washington University

Hailyn Nielsen, MD, PhD

Rheumatology, UCSF

2015 University of Chicago

Vaibhav Upadhyay, MD, PhD

Pulmonary Disease and Critical Care Medicine, UCSF

2014 Harvard

Vincent Auyeung, MD, PhD

Pulmonary Disease and Critical Care Medicine, UCSF

2014 UCSF

Alan Baik, MD

Cardiology, UCSF

2014 UCSF

Jonathan Chou, MD, PhD

Hematology and Oncology, UCSF

2014 University of Washington

Joseph Hiatt, MD, PhD

Hematology and Oncology, University of Washington

Application Logistics

Upon receipt of the electronic Residency Application from ERAS, the Residency Admissions Committee selects applicants for interview at UCSF. Applicants invited for an interview are then asked if they wish to be considered for the Molecular Medicine Residency. A separate selection committee reviews applicants and issues invitations to remain an extra day after the Categorical Residency application day to interview specifically for the Molecular Medicine Residency.

As stated above, acceptance into the Molecular Medicine Residency includes a commitment of a fellowship position in a specialty of choice. A Molecular Medicine Residency participant, however, may also choose not to specify a particular specialty and, instead, wait to apply after exploring different opportunities during residency.

The UCSF Molecular Medicine Residency Program is fully committed to enhancing diversity at UCSF.
Applications from women and under-represented ethnic/cultural groups are strongly encouraged.

Neil P. Shah, MD PhD
Director, UCSF Molecular Medicine Residency Program

Aparna Sundaram, MD
Associate Director, UCSF Molecular Medicine Residency Program

Contact Us

Additional questions may be addressed to Eva Gamboa.

Eva Gamboa
[email protected]

Thank you for your interest in the UCSF Molecular Medicine Residency Program.